Goldsite Diagnostics Inc

Goldsite, also known as Guosai Biotechnology Co., Ltd., is a company that specializes in the development and production of in-vitro diagnostics (IVD) products and related reagents. The company's product range includes various analysis instruments, such as protein analysis, glycated hemoglobin analysis, and blood cell analysis instruments, as well as library preparation systems and test reagents, including those for new coronavirus antigen testing. In addition to its products, Goldsite also provides technical training, after-sales service, and medical application support to its customers.

Goldsite Diagnostics Inc., headquartered in Shenzhen, PR China, is a leading global in vitro diagnostics (IVDs) provider of reliable and consistent products, solutions, and services that meet stringent requirements for hospitals, labs, physician offices and clinics.

For nearly two decades, Goldsite Diagnostics has been committed to IVDs for a sustainable and better future of human healthcare with in-depth diagnostic expertise, state-of-the-art R&D facilities, a versatile product offering, large-scale GMP production and manufacturing, and global technical support.

As a pioneer in the specific proteins tests in China, Goldsite Diagnostics has devoted its innovation to revitalizing medical industry by initiating the prospective studies of specific proteins to improve people’s lives.

Goldsite Diagnostics’ operation is certified to the ISO 13485: 2003 by the Det Norske Veritas and Germanischer Lloyd (DNV GL) to facilitate harmonized medical device regulatory requirements for quality management systems.

COVID-19
Specific Protein
Chemistry
Chemiluminescence
TRFIA
HPLC
Veterinary